Ronald C Renaud JR insider trades

Open-market stock purchases and sales by Ronald C Renaud JR, CEO & President at Kailera Therapeutics, Inc, from SEC Form 4 filings since Feb 10, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -93%.

Recent trades

DateStockTradeValue
Jun 9, 2026KLRA Kailera Therapeutics, IncBought (not open market)—
Jun 9, 2026UPB Upstream Bio, IncBought (not open market)—
Apr 16, 2026KLRA Kailera Therapeutics, IncBought (not open market)—

Companies traded

  • KLRA Kailera Therapeutics, Inc: other filings, last Jun 9, 2026
  • UPB Upstream Bio, Inc: other filings, last Jun 9, 2026
  • CERE Cerevel Therapeutics Holdings, Inc: 1 buy, last Aug 1, 2024
  • ATRA Atara Biotherapeutics, Inc: other filings, last Jun 23, 2022
  • IKNA Ikena Oncology, Inc: other filings, last Jun 9, 2022
  • TBIO Translate Bio, Inc: 8 sales, last Sep 14, 2021
  • CMRX Chimerix Inc: other filings, last Jun 20, 2019
  • AKBA Akebia Therapeutics, Inc: 1 buy, last Jun 14, 2018
  • PTCT PTC Therapeutics, Inc: other filings, last Jan 3, 2017
  • IDIX Idenix Pharmaceuticals Inc: other filings, last Aug 5, 2014

Get free alerts when Ronald C Renaud JR files a new trade →